LeMaitre Vascular (NSDQ:LMAT) said last week that it agreed to put up $14 million for tissue preservation service provider Restore Flow Allografts. The deal calls for Burlington, Mass.-based LeMaitre to pay $12 million up front and another $2 million in May 2018, plus earn-puts pegged to sales performance over the next 2 years. Fox River Grove, Ill.-based Restore […]
Vascular
Coating issue rears its head for Concert Medical’s Galeo Pro guidewire
Concert Medical yesterday issued a voluntary recall notice for certain lots of its Galeo Pro coronary guidewires over issues with the polytetrafluoroethylene coating separating from the device. The company said it initiated the recall because of the risk of the PTFE coating separating or detaching on the device, which could cause PTFE particulate to enter […]
Appeals court denies inventor in patent spat with Endologix pickup TriVascular
A federal appeals court yesterday upheld a lower court’s ruling on the claim construction in a patent infringement dispute between the inventor of a vascular stent patent and Endologix (NSDQ:ELGX) acquisition TriVascular Technologies. In February, the U.S. Court of Appeals for the Federal Circuit upheld a Patent Trial & Appeal Board ruling that the patent was not invalid due to obviousness. […]
Neuravi raises $16.7m
Neuravi said today it raised $16.7 million (EU €15 million) in a new round of debt financing, with funds slated to support U.S. commercialization and portfolio expansion. Money in the round came from healthcare alternative financing provider IPF Partners, the Galway, Ireland-based company said. Funds raised in the round will be invested into the U.S. commercialization […]
There’s no quit in Abbott whistleblower Colquitt
The whistleblower behind a decade-old lawsuit against Abbott (NYSE:ABT) won’t say die, asking a federal appeals court last week to order a new trial after a jury shot him down earlier this year. Former Guidant sales rep Kevin Colquitt sued Abbott, Johnson & Johnson (NYSE:JNJ) and Boston Scientific (NYSE:BSX) in 2006 for $219.4 million, claiming that they marketed the use of biliary stents […]
Medtronic wins FDA nod for lower-profile HawkOne atherectomy device
Medtronic (NYSE:MDT) said today it won FDA 510(k) clearance for a new lower profile version of its HawkOne directional atherectomy system, designed for treating patients with peripheral artery disease. The Fridley, Minn.-based company’s HawkOne is a directional atherectomy device designed to treat severely calcified lesions in the blood vessels of the lower extremities. The device […]
FDA adds diagnostic indication for Avinger’s Pantheris atherectomy device
Avinger (NSDQ:AVGR) said today it won expanded indications from the FDA for its Pantheris Lumivascular atherectomy system, now cleared for diagnostic imaging as well as treatment for peripheral artery disease. The Redwood City, Calif.-based company touted the win, saying its Pantheris is the 1st and only image-guided atherectomy device to receive clearances as both a diagnostic […]
Abbott, St. Jude Medical to deal vascular assets to Terumo for $1B
Abbott (NYSE:ABT) and St. Jude Medical (NYSE:STJ), the subject of a pending, $25 billion acquisition by Abbott, agreed to deal some of their respective vascular assets to Japan’s Terumo Corp. (TYO:4543) for about $1.12 billion. The sale involves St. Jude’s Angio-Seal and Femoseal vascular closure devices and Abbott’s Vado steerable sheath, the companies said today. Abbott […]
Medtronic touts cryoballoon cost savings data from Fire & Ice trial
Medtronic (NYSE:MDT) today released new economic analysis data from the Fire and Ice trial comparing cryoballoon catheter ablation with radiofrequency ablation, touting advantages of cryoballoon treatment over RF. Data from the trial was presented at the Asia Pacific Heart Rhythm Society’s Scientific Sessions in Seoul. Primary results from the trial were published in The New […]
Study: Endovascular aneurysm repair shows higher long-term mortality
Endovascular repair of abdominal aortic aneurysms showed a higher mortality rate over the long term compared with open surgical repair, according to a study published yesterday in The Lancet. The study, “Endovascular versus open repair of abdominal aortic aneurysm in 15-years’ follow-up of the UK endovascular aneurysm repair trial 1,” was based on data from the […]
Researchers develop personalized 3D-printed vascular stents
Researchers from Northwestern University have developed a 3D-printed vascular stent that can be personalized to the patient, the school reported this week. The stents are made of a biodegradable, citric acid-based polymer that researchers could load with drugs to release slowly as the blood vessel wall heals. “Right now, the vast majority of stents are […]